This HTML5 document contains 200 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1111/
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q39293750
rdf:type
wikibase:Item
schema:description
article scientific naučni članak tudományos cikk bài báo khoa học bilimsel makale 2012年論文 επιστημονικό άρθρο наукова стаття, опублікована у вересні 2012 artigo científico scientific article published on 28 September 2012 2012 nî lūn-bûn scientific article published on 28 September 2012 2012年论文 artículu científicu espublizáu en 2012 2012年论文 artikull shkencor teaduslik artikkel 2012年論文 artigo científico 2012年論文 vědecký článek 2012年论文 article scientifique научная статья artikel ilmiah videnskabelig artikel 2012年論文 სამეცნიერო სტატია научни чланак artículo científico publicado en 2012 vitenskapelig artikkel ২৮ সেপ্টেম্বর ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article published on 28 September 2012 articolo scientifico مقالة علمية نشرت في 28 سبتمبر 2012 2012年论文 article científic vedecký článok מאמר מדעי articol științific vitskapeleg artikkel artigo científico 2012年の論文 wetenschappelijk artikel 2012年论文 vetenskaplig artikel 2012年论文 scienca artikolo научна статия wissenschaftlicher Artikel tieteellinen artikkeli บทความทางวิทยาศาสตร์ artikulong pang-agham artykuł naukowy 2012年論文 мақолаи илмӣ 2012년 논문 научни чланак
p:P577
wds:Q39293750-8EBD532A-9879-462D-B3C8-FC42F30A397A
wdt:P577
2012-09-28T00:00:00Z
p:P2860
wds:Q39293750-A28BF768-FFA1-4757-81BD-35E5724AC325 wds:Q39293750-A90D5896-4DD7-4B05-B07D-508F396F0410 wds:Q39293750-AD1102FF-5F9A-4D2D-A3C4-07D0CEF3350F wds:Q39293750-B0641957-0EA1-4B70-A838-724D7BBF1BC9 wds:Q39293750-D2812BDF-7D63-4BF3-BECC-72501782411C wds:Q39293750-D91DFE8C-B0CC-48FD-9704-67617B54EC19 wds:Q39293750-E50A447B-5802-4813-9D2F-D2976809CD31 wds:Q39293750-E563478B-902D-424C-BD71-A33728DB060C wds:Q39293750-C1EF1A5F-4A6E-4AB6-92C7-DF86DC7D410D wds:Q39293750-C2CFB17A-DB4F-4F0E-AB4C-6FD280977846 wds:Q39293750-D1087A82-AF08-4D0C-8D2D-75FEE95ED6E5 wds:Q39293750-D1D5E692-17A4-4700-A9C8-1BB4A2118015 wds:Q39293750-F4FD8401-DC66-48F3-8C12-5AEE4FB25CC2 wds:Q39293750-E5B2E4A3-4499-48E5-894B-FCBBA8B3222E wds:Q39293750-E89AFA17-290A-4B47-BD95-153787275787 wds:Q39293750-11F65E8B-6141-4E22-8ECE-CB6425BF2ED6 wds:Q39293750-1C58C2B5-933C-4CDF-B2CE-00D2DC762CD3 wds:Q39293750-031F1B52-7CCA-4183-9B56-9BA495EBAFDE wds:Q39293750-0891414D-9D91-4281-A54E-DD0A77207999 wds:Q39293750-37EA62C1-C5A3-4EB3-BBF0-184ED4B2C910 wds:Q39293750-397F823F-5053-431B-8AB8-58F5CF0BE18B wds:Q39293750-3B98C7E7-E839-4E73-AB38-D0548E5380A5 wds:Q39293750-3C6E4B16-292F-4DF8-AFBA-6288E5C0041D wds:Q39293750-2110B8BD-7980-4421-B4F8-03DE1E9F1A1B wds:Q39293750-34360B42-01C3-4DB7-B79F-03BFC18F8BD6 wds:Q39293750-575160EF-AD62-45D6-A776-F46CD7E0B0A8 wds:Q39293750-642F406E-0E12-428D-945D-F085AD904FAE wds:Q39293750-6890C23D-BF5B-4D4C-AEB6-CC846E983525 wds:Q39293750-4953DFCE-A5AA-4F5B-8E14-9D968F6A8B8F wds:Q39293750-542297F2-75CF-401E-849B-596D6A9B6174 wds:Q39293750-56F3ADE0-ECB0-4467-8A2F-25672A813D7C wds:Q39293750-7D4EF2FD-8786-4037-8A1C-88A2E5D5D530 wds:Q39293750-7ED65FD6-EA40-4FF0-891A-2A6F94D6BE5C wds:Q39293750-854982CA-D2D5-407D-9FFC-04476C329A97 wds:Q39293750-6B5C20BF-06CC-4DA2-982B-AEB17B8A31F0 wds:Q39293750-6E9BE776-616E-400A-96DC-9B24643E9A59 wds:Q39293750-6EF22418-BE86-46FD-A852-0B9FADF24AAD wds:Q39293750-6FE113DC-39CB-44F6-B69A-86E279505707 wds:Q39293750-93870D45-9E8B-4D56-8DC5-3A2EBDFD243B wds:Q39293750-93CC41C0-B4CB-4D83-904F-CB39850FAFC1 wds:Q39293750-96B59A1A-6991-48A2-8627-2EE62FD382B6 wds:Q39293750-996A76C9-21CA-4DC8-87A0-09FFF742C693 wds:Q39293750-86B7EEDE-E718-4A9B-82C8-0912D417FC72 wds:Q39293750-888EED3C-C884-4C45-90BC-14CE624DAAD8 wds:Q39293750-8D57AB21-12CB-446E-982A-C08D6175E103 wds:Q39293750-BF7E8AEF-8132-43ED-B72E-5723797A4C6F wds:Q39293750-C01EFB19-5018-4137-91AB-26C6CCF41E3A
wdt:P2860
wd:Q39744078 wd:Q40780120 wd:Q34692321 wd:Q51051603 wd:Q40156180 wd:Q40408896 wd:Q40209827 wd:Q36426098 wd:Q39556098 wd:Q45039241 wd:Q43778471 wd:Q34265381 wd:Q28139460 wd:Q39735370 wd:Q34311756 wd:Q37409025 wd:Q81482708 wd:Q71091026 wd:Q46028085 wd:Q24598974 wd:Q41917818 wd:Q28257238 wd:Q37636192 wd:Q40736533 wd:Q36840281 wd:Q40669542 wd:Q41139581 wd:Q44260085 wd:Q64988743 wd:Q34433202 wd:Q36368332 wd:Q33634544 wd:Q40898177 wd:Q35862179 wd:Q33376033 wd:Q34348874 wd:Q36172902 wd:Q36918394 wd:Q40408197 wd:Q74530744 wd:Q41483867 wd:Q24676613 wd:Q33204839 wd:Q53650886 wd:Q36172577 wd:Q39829091 wd:Q71636846
p:P2093
wds:Q39293750-07660188-4227-479E-8DA1-0F8767E8E813 wds:Q39293750-155DC3B2-8D6D-4820-BC14-5130D3C47E91 wds:Q39293750-12C52F7C-1CEC-4462-BEAA-8D2035A18AD2 wds:Q39293750-EB983A04-4C1A-415B-9A03-9A0705C0CD33 wds:Q39293750-EE542B9E-A932-4862-AA4F-29C10EF41578 wds:Q39293750-C1809F44-3B97-4120-8D4C-6E819EFE16C4 wds:Q39293750-3E985FC5-FB0B-4EB5-9CEA-11229D61815E wds:Q39293750-75292FBC-D488-4236-B04F-BA3F593AD144
wdt:P2093
Ya-Ling Cao Dian-Chun Fang Zhong-Li Liao Yu-Yun Wu Hong Guo Xu-Dong Tang Shi-Ming Yang Mu-Han Lü
rdfs:label
Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase (hTERT). Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase (hTERT).
skos:prefLabel
Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase (hTERT). Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase (hTERT).
schema:name
Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase (hTERT). Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase (hTERT).
p:P1476
wds:Q39293750-F9804116-4139-4AF7-8B77-9D0CF4829FFE
wdt:P1476
Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase (hTERT).
p:P304
wds:Q39293750-F6E90360-543C-4398-A17C-43BF20F90710
wdt:P304
1920-1928
p:P31
wds:Q39293750-EFEDABFD-4D3E-41CA-9650-6E36A46737A4
wdt:P31
wd:Q13442814
p:P698
wds:Q39293750-B874D53E-1DD6-448E-B732-AC5E8DB93FDA
wdtn:P698
n8:22909416
wdt:P698
22909416
p:P1433
wds:Q39293750-0D288B24-48D0-42BC-B0C7-F419B3D66947
wdt:P1433
wd:Q326125
p:P433
wds:Q39293750-34F3FCB9-0744-4F07-B463-98FEC020C3B5
p:P478
wds:Q39293750-FEB91FD1-CDAE-468A-BB5E-41426160976D
wdt:P433
11
wdt:P478
103
p:P356
wds:Q39293750-2CECA21D-E3AD-4DDB-A061-6BBA737E9B6F
wdtn:P356
n9:J.1349-7006.2012.02410.X
wdt:P356
10.1111/J.1349-7006.2012.02410.X
p:P5875
wds:Q39293750-62A1F541-3BAC-4C9F-80EB-D972886CC44F
wdt:P5875
230713268